LILRA2 antibody

Este producto es parte de LILRA2 - leukocyte immunoglobulin like receptor A2
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
LILRA2 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab04775
tested applications
ELISA, WB, IHC

Description

Does not bind class I MHC antigens.

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
leukocyte immunoglobulin-like receptor, subfamily A(with TM domain), member 2 (LILRA2)
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1:500-1:2000; IHC: 1:20-1:200
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
53kd
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IHC
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
Q8N149
Gene ID
11027
Alias
Leukocyte immunoglobulin-like receptor subfamily A member 2,ILT1,LIR7,CD85H,LIR-7,Immunoglobulin-like transcript 1,Leukocyte immunoglobulin-like receptor 7
Background
Antibody anti-LILRA2
Status
RUO
Note
Mol. Weight 53 kDa

Descripción

LILRA2, also known as Leukocyte Immunoglobulin-Like Receptor A2 (LILRA2) or CD85h, is a member of the immunoglobulin superfamily and part of the leukocyte immunoglobulin-like receptor (LILR) family. This receptor is encoded by the LILR gene cluster on chromosome 19q13.4, which is home to various immunoglobulin-like receptors involved in immune regulation. LILRA2 plays an activating role in immune response modulation and is predominantly expressed on monocytes, macrophages, and some other leukocyte subsets, such as granulocytes. It is essential in host defense, participating in immune responses to infections and modulating inflammation through cellular signaling pathways. The receptor interacts with a variety of ligands, likely including MHC class I molecules, which allows it to influence both innate and adaptive immunity. The immune-modulating role of LILRA2 makes it an essential subject of study in the context of immune responses and inflammation. Unlike other LILR members that may provide inhibitory signaling, LILRA2 is classified as an activating receptor, generally enhancing immune responses through its interaction with signaling adaptors that contain immunoreceptor tyrosine-based activation motifs (ITAMs). This activating function of LILRA2 contrasts with some members of the LILRB subfamily, which contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and thus help suppress immune responses. Research has shown that aberrant expression or dysregulation of LILRA2 can contribute to inflammatory diseases, autoimmunity, and potentially cancer, making it a focal point for therapeutic interventions.

Related Products

EH2451

Human LILRA2 (Leukocyte immunoglobulin-like receptor subfamily A member 2) ELISA Kit

Ver Producto
FNab04775

LILRA2 antibody

Does not bind class I MHC antigens.

Ver Producto
Pr23027

Recombinant Human LILRA2

Ver Producto